The Effects of Omega-3 Fatty Acids on Aspirin Resistance.

Trial Profile

The Effects of Omega-3 Fatty Acids on Aspirin Resistance.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 24 Oct 2012

At a glance

  • Drugs Aspirin; Omega-3-acid ethyl esters
  • Indications Cardiovascular disorders; Embolism and thrombosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 28 Jun 2012 Actual patient numbers amended from 26 to 27 as reported by ClinicalTrials.gov.
    • 28 Jun 2012 Primary endpoint changed from platelet aggregation to time to clot formation as reported by ClinicalTrials.gov.
    • 24 Feb 2010 Actual end date (Jan 2009) and actual number of patients (26) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top